Physician profile
Victor Vanberkel
NPI 1083740757
$5,067.24
in general payments reported to CMS, 2019-2025
47 companies · $710 in 2025
The $710 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,542 · 2020: $341 · 2021: $260 · 2022: $556 · 2023: $947 · 2024: $709 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,285 · Education: $81.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,284.91 |
| Education | $81.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,652.50 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Intuitive Surgical, INC. | $1,329.39 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $238.47 | 2020-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Astrazeneca Pharmaceuticals LP | $204.54 | 2020-2025 | Tagrisso, Imfinzi |
| Ethicon INC. | $184.94 | 2020-2025 | Monarch Platform |
| Novartis Pharmaceuticals Corporation | $109.70 | 2019-2024 | |
| Amgen INC. | $106.15 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.63 | 2020-2025 | |
| Covidien LP | $78.22 | 2019 | |
| Incyte Corporation | $76.13 | 2024-2025 | Jakafi, Monjuvi, Pemazyre |
| Kls-Martin L.P. | $73.03 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $71.43 | 2023-2025 | Libtayo |
| Lilly USA, LLC | $60.91 | 2020-2024 | Verzenio, Jaypirca, Retevmo |
| Stryker Corporation | $60.57 | 2020 | |
| Mirati Therapeutics, INC. | $57.45 | 2023 | Krazati |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Vanberkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.